Delineating dyspnea Because multiple pathologic processes likely contribute to progressive dyspnea in patients with coexisting heart and lung diseases, it is unlikely that a single causative agent can ...

Please provide your email address to receive an email when new articles are posted on . Across several subgroups, more patients receiving ensifentrine vs. placebo were classified as Transitional ...

Please provide your email address to receive an email when new articles are posted on . This analysis focused on adults with moderate to severe COPD without an exacerbation during the ENHANCE trials.

Among patients with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, short-term daily treatment with low doses of extended-release morphine did not significantly reduce ...

The mean projection of patients' emotions and dyspnea was more optimistic than what was eventually observed. Patients with chronic obstructive pulmonary disease (COPD) who have overoptimistic ...

A common treatment for the breathlessness experienced by many people with chronic obstructive pulmonary disease (COPD) relies on the use of a positive-expiratory pressure (PEP) device, which sends ...

When a patient calls a primary care provider due to shortness of breath symptoms, recommending an in-office examination is generally warranted. Your patient may explain how they are out of breath from ...

"Oh, that's just from smoking." It's easy to dismiss a chronic cough as another problem with cigarettes. But what if it's a sign of the lung disease COPD? Franziska Gabbert/dpa Long-term smokers often ...

Quantitative CT in AATD linked airway wall thickening and bronchiectasis to lung function, while wall thickness best ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...